Atara Biotherapeutics (ATRA) Other Accumulated Expenses (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Other Accumulated Expenses of $3.46 million for Q2 2026, down 54.9% from $7.67 million a year earlier but up 17.7% from the prior quarter.
Atara Biotherapeutics (ATRA) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics posted Other Accumulated Expenses of $2.98 million, down 85.2% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $20.16 million in FY2024 (-36.7%), $31.83 million in FY2023 (+27.3%), $24.99 million in FY2022 (+85.8%) and $13.45 million in FY2021 (-14.9%).
- Five-year quarterly Other Accumulated Expenses spans a low of $2.94 million in Q1 2026 and a high of $33.05 million in Q1 2024.
- Year over year, Other Accumulated Expenses has now declined in each of the last eight quarters, with an average decline of 55.5% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2022 (growth of 128.7%); the low point was Q1 2026 (a decline of 87.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.94 million (Q1 2026), $2.98 million (Q4 2025) and $4.65 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Atara Biotherapeutics | 142.51 Mn | 132.61 Mn | 439,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.46 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Jun 30, 2025 | 7.67 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 23.64 Mn |
| Jun 30, 2024 | 26.15 Mn |
| Mar 31, 2024 | 33.05 Mn |
| Dec 31, 2023 | 31.83 Mn |
| Sep 30, 2023 | 23.97 Mn |
| Jun 30, 2023 | 25.17 Mn |
| Mar 31, 2023 | 23.77 Mn |
| Dec 31, 2022 | 24.99 Mn |
| Sep 30, 2022 | 22.81 Mn |
| Jun 30, 2022 | 19.78 Mn |
| Mar 31, 2022 | 13.99 Mn |
| Dec 31, 2021 | 13.45 Mn |
| Sep 30, 2021 | 9.97 Mn |
Atara Biotherapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();